Post-market Safety Study of LUMISIGHT
Post-market Safety Study of LUMISIGHT
Not yet recruiting · NCT07572162 · Registry updated 2026-05-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-market Safety Study of LUMISIGHT | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, Neoplasms by Site, Skin and Connective Tissue Diseases, anaphylaxis, breast disorder, breast neoplasm, drug allergy, immune system disorder, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-05-07 | NCT07572162 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lumicell, Inc. | 3 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||